Targets for LDL-lowering therapy.


PURPOSE OF REVIEW To compare non-HDL-cholesterol (non-HDL-C) and apolipoprotein B (apoB) as targets for LDL-lowering therapy. The conventional approach is restricted to a comparison of in-trial data. Although essential, this overlooks the issue as to which marker better identifies residual risk after any particular treatment regimen. RECENT FINDINGS Data… (More)
DOI: 10.1097/MOL.0b013e32832ca1d6


Cite this paper

@article{Sniderman2009TargetsFL, title={Targets for LDL-lowering therapy.}, author={Allan David Sniderman}, journal={Current opinion in lipidology}, year={2009}, volume={20 4}, pages={282-7} }